Cargando…
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules
Computer aided drug-design methods proved to be powerful tools for the identification of new therapeutic agents. We employed a structure-based workflow to identify new inhibitors targeting mTOR kinase at rapamycin binding site. By combining molecular dynamics (MD) simulation and pharmacophore modell...
Autores principales: | Vittorio, Serena, Gitto, Rosaria, Adornato, Ilenia, Russo, Emilio, De Luca, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922000/ https://www.ncbi.nlm.nih.gov/pubmed/33669763 http://dx.doi.org/10.3390/molecules26041103 |
Ejemplares similares
-
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease
por: Vittorio, Serena, et al.
Publicado: (2020) -
mTOR kinase structure, mechanism and regulation by the rapamycin-binding domain
por: Yang, Haijuan, et al.
Publicado: (2013) -
In Silico Identification of Potential Druggable Binding Sites on CIN85 SH3 Domain
por: Vittorio, Serena, et al.
Publicado: (2021) -
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes
por: Lisi, Lucia, et al.
Publicado: (2011) -
Evaluation of 4‐(4‐Fluorobenzyl)piperazin‐1‐yl]‐Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects
por: Mirabile, Salvatore, et al.
Publicado: (2021)